Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China
· Delayed Price · Currency is CNY 93.57
+1.50 (1.63%)
Apr 29, 2026, 3:00 PM CST
SHA:688578 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 2,415 | 2,189 | 1,430 | 644.17 | 130.52 | 18.27 | Upgrade
|
| Depreciation & Amortization | 42.21 | 42.21 | 38.61 | 39.39 | 25.25 | 23.46 | Upgrade
|
| Other Amortization | 2.3 | 2.3 | 1.19 | 0.79 | 1.77 | 2.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.02 | - | -0.02 | -0.03 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.27 | 3.27 | 0.01 | 0.03 | 1.71 | -34.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | -53.99 | -53.99 | -35.58 | -32.58 | -45.01 | -66.01 | Upgrade
|
| Stock-Based Compensation | 25.43 | 25.43 | 78.26 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.04 | -0.04 | 0.16 | -0.71 | 1.36 | 0.5 | Upgrade
|
| Other Operating Activities | -107.25 | -42.98 | -45.21 | -36.02 | -29.53 | 4.72 | Upgrade
|
| Change in Accounts Receivable | -13.63 | -13.63 | -186.03 | -163.84 | -108.57 | 8.22 | Upgrade
|
| Change in Inventory | -38.29 | -38.29 | 32.39 | -30.88 | -10.62 | -12.34 | Upgrade
|
| Change in Accounts Payable | 217.76 | 217.76 | 238.62 | 184.14 | 67.38 | 10.89 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 75.03 | 68.91 | 73.69 | Upgrade
|
| Operating Cash Flow | 2,484 | 2,323 | 1,566 | 674.65 | 91.63 | 29.29 | Upgrade
|
| Operating Cash Flow Growth | 55.86% | 48.31% | 132.12% | 636.28% | 212.82% | - | Upgrade
|
| Capital Expenditures | -136.55 | -186 | -270.22 | -67.88 | -143.83 | -192.25 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Investment in Securities | -1,943 | -1,943 | -1,645 | 1,416 | 81.63 | 599.99 | Upgrade
|
| Other Investing Activities | 717.14 | 92.9 | 80.08 | -1,255 | -342.02 | -168.56 | Upgrade
|
| Investing Cash Flow | -1,362 | -2,036 | -1,835 | 92.75 | -404.21 | 239.19 | Upgrade
|
| Long-Term Debt Issued | - | 0.1 | - | - | - | - | Upgrade
|
| Total Debt Issued | 0.1 | 0.1 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.01 | -2.38 | -2.58 | -4.87 | -8.97 | Upgrade
|
| Total Debt Repaid | -3.01 | -3.01 | -2.38 | -2.58 | -4.87 | -8.97 | Upgrade
|
| Net Debt Issued (Repaid) | -2.91 | -2.91 | -2.38 | -2.58 | -4.87 | -8.97 | Upgrade
|
| Common Dividends Paid | -360 | -360 | -292.5 | - | - | - | Upgrade
|
| Other Financing Activities | -0.15 | -0.11 | -0.16 | 0.37 | 1.19 | -8 | Upgrade
|
| Financing Cash Flow | -363.06 | -363.02 | -295.05 | -2.21 | -3.69 | -16.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.89 | -1.09 | 2.84 | 4.35 | 17.17 | -3.38 | Upgrade
|
| Net Cash Flow | 757.78 | -77.34 | -561.36 | 769.55 | -299.1 | 248.13 | Upgrade
|
| Free Cash Flow | 2,347 | 2,137 | 1,296 | 606.77 | -52.21 | -162.95 | Upgrade
|
| Free Cash Flow Growth | 78.85% | 64.88% | 113.56% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 41.38% | 41.19% | 36.42% | 30.06% | -6.60% | -30.74% | Upgrade
|
| Free Cash Flow Per Share | 5.21 | 4.74 | 2.88 | 1.35 | -0.12 | -0.36 | Upgrade
|
| Cash Income Tax Paid | 1,091 | 1,002 | 566.32 | 243.72 | 12.82 | -15.03 | Upgrade
|
| Levered Free Cash Flow | 1,445 | 1,453 | 823.28 | 378.35 | -56.71 | -120.89 | Upgrade
|
| Unlevered Free Cash Flow | 1,445 | 1,453 | 823.32 | 378.45 | -56.5 | -120.51 | Upgrade
|
| Change in Working Capital | 157.24 | 157.24 | 98.74 | 59.58 | 5.59 | 80.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.